$CSR
Centerspace Stock $csr

$csr Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000079835924000100 Filed on July 29, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$65.03M	$65.04M
YoY Change	0.71%	0.41%
Cost Of Revenue	$2.242M	$2.222M
YoY Change	2.05%	-91.86%
Gross Profit	$62.78M	$62.82M
YoY Change	0.66%	67.6%
Gross Profit Margin	96.55%	96.58%
Selling, General & Admin	$5.001M	$4.958M
YoY Change	30.51%	19.13%
% of Gross Profit	7.97%	7.89%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$26.38M	$26.01M
YoY Change	5.65%	5.53%
% of Gross Profit	42.02%	41.4%
Operating Expenses	$31.08M	$30.67M
YoY Change	8.96%	7.5%
Operating Profit	$6.350M	$7.192M
YoY Change	-63.5%	-19.64%
Interest Expense	-$8.301M	-$8.855M
YoY Change	-197.02%	6.1%
% of Operating Profit	-130.72%	-123.12%
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.951M	-$1.663M
YoY Change	-121.28%	-30.13%
Income Tax
% Of Pretax Income
Net Earnings	-$1.048M	-$1.296M
YoY Change	-113.48%	-62.65%
Net Earnings / Revenue	-1.61%	-1.99%
Basic Earnings Per Share	-$0.40	-$0.19
Diluted Earnings Per Share	-$0.40	-$0.19
COMMON SHARES
Basic Shares Outstanding	15.30M shares	14.91M shares
Diluted Shares Outstanding	15.53M shares	14.97M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.45M	$14.33M
YoY Change	-51.34%	47.03%
Cash & Equivalents	$14.45M	$14.33M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$14.45M	$14.33M
YoY Change	-51.34%	47.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.834B	$1.850B
YoY Change	1.35%	-2.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.794M	$1.084M
YoY Change	-87.58%	91.52%
Total Long-Term Assets	$1.873B	$1.885B
YoY Change	1.32%	-1.33%
TOTAL ASSETS
Total Short-Term Assets	$14.45M	$14.33M
Total Long-Term Assets	$1.873B	$1.885B
Total Assets	$1.887B	$1.899B
YoY Change	0.49%	-1.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$61.00M	$52.89M
YoY Change	-2.67%	-6.75%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$61.00M	$52.89M
YoY Change	-2.67%	-6.75%
LONG-TERM LIABILITIES
Long-Term Debt	$921.3M	$931.7M
YoY Change	9.85%	5.69%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$921.3M	$931.7M
YoY Change	9.85%	5.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$61.00M	$52.89M
Total Long-Term Liabilities	$921.3M	$931.7M
Total Liabilities	$982.3M	$984.6M
YoY Change	8.98%	-15.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$597.7M	-$579.1M
YoY Change	13.29%	10.78%
Common Stock	$1.271B	$1.167B
YoY Change	8.7%	-0.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$672.5M	$680.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.887B	$1.899B
YoY Change	0.49%	-1.08%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$1.048M	-$1.296M
YoY Change	-113.48%	-62.65%
Depreciation, Depletion And Amortization	$26.38M	$26.01M
YoY Change	5.65%	5.53%
Cash From Operating Activities	$32.32M	$22.86M
YoY Change	1.44%	-3.77%
INVESTING ACTIVITIES
Capital Expenditures	$11.85M	$13.78M
YoY Change	-17.32%	-0.43%
Acquisitions
YoY Change
Other Investing Activities	-$194.0K	-$5.608M
YoY Change	-100.24%	5344.66%
Cash From Investing Activities	-$12.04M	-$19.38M
YoY Change	-117.68%	39.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-18.44M	-1.813M
YoY Change	-68.26%	-96.84%
NET CHANGE
Cash From Operating Activities	32.32M	22.86M
Cash From Investing Activities	-12.04M	-19.38M
Cash From Financing Activities	-18.44M	-1.813M
Net Change In Cash	1.835M	1.664M
YoY Change	-95.62%	-103.5%
FREE CASH FLOW
Cash From Operating Activities	$32.32M	$22.86M
Capital Expenditures	$11.85M	$13.78M
Free Cash Flow	$20.47M	$9.085M
YoY Change	16.79%	-8.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Stockholders Equity Other StockholdersEquityOther	140000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	965408000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	931025000	usd
	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-6775000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.50
	us-gaap	Dividends Common Stock DividendsCommonStock	23712000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1481000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9269000	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	123701000	usd
	us-gaap	Variable Lease Income VariableLeaseIncome	6845000	usd
	us-gaap	Variable Lease Income VariableLeaseIncome	6517000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2276000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2455000	usd
	us-gaap	Revenues Revenues	132673000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-577000	usd
CY2023Q2	csr	Property Operating Expense PropertyOperatingExpense	25046000	usd
CY2023Q2	csr	Net Operating Income Loss NetOperatingIncomeLoss	39730000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2247000	usd
CY2023Q2	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-53000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24371000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-67000	usd
CY2023Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2864000	usd
CY2023Q2	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	295000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2380000	usd
	us-gaap	Revenues Revenues	129549000	usd
	csr	Property Operating Expense PropertyOperatingExpense	50258000	usd
	csr	Net Operating Income Loss NetOperatingIncomeLoss	79291000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4552000	usd
	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-1330000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52726000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8839000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-577000	usd
	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	817000	usd
	us-gaap	Profit Loss ProfitLoss	-6455000	usd
	us-gaap	Revenues Revenues	132673000	usd
	csr	Property Operating Expense PropertyOperatingExpense	53969000	usd
	csr	Net Operating Income Loss NetOperatingIncomeLoss	78704000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4815000	usd
	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-305000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50364000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11885000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	60092000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2864000	usd
	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	344000	usd
	us-gaap	Profit Loss ProfitLoss	49947000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000798359
	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	0	usd
	us-gaap	Stockholders Equity Other StockholdersEquityOther	45000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	898297000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	987805000	usd
CY2023Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-2540000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.73
CY2023Q2	us-gaap	Dividends Common Stock DividendsCommonStock	11608000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4703000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	21879000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3214000	usd
	csr	Payments Of Ordinary Dividends Preferred Unitholders PaymentsOfOrdinaryDividendsPreferredUnitholders	320000	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	4809000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-140000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-164387000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1580000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11891000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15412000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10311000	usd
	csr	Conversion Of Stock Amount Converted Net ConversionOfStockAmountConvertedNet	-1021000	usd
CY2023Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11608000	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	2120000	usd
	csr	Noncash Or Part Noncash Transaction Retirement Of Shares Withheld For Taxes NoncashOrPartNoncashTransactionRetirementOfSharesWithheldForTaxes	179000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2864000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1060000	usd
CY2023Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Advertising Expense AdvertisingExpense	1500000	usd
	us-gaap	Advertising Expense AdvertisingExpense	1400000	usd
	us-gaap	Net Income Loss NetIncomeLoss	41708000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	38494000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable	-7854000	usd
	csr	Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount	320000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	46668000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14947000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14987000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14987000	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	967000	shares
CY2023Q2	csr	Incremental Common Shares Attributable To Conversion Of Restricted Stock IncrementalCommonSharesAttributableToConversionOfRestrictedStock	0	shares
	csr	Incremental Common Shares Attributable To Conversion Of Restricted Stock IncrementalCommonSharesAttributableToConversionOfRestrictedStock	0	shares
	csr	Incremental Common Shares Attributable To Conversion Of Restricted Stock IncrementalCommonSharesAttributableToConversionOfRestrictedStock	20000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14949000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14947000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18313000	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.57
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.55
CY2023Q4	csr	Noncontrolling Interests In Operating Partnership Units Outstanding NoncontrollingInterestsInOperatingPartnershipUnitsOutstanding	861000	shares
CY2023Q2	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	54.51
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	88000	shares
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4703000	usd
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	53.62
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	124000	shares
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	6718000	usd
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	54.19
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3214000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	38494000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	csr	Property Operating Expenses Excluding Real Estate Taxes PropertyOperatingExpensesExcludingRealEstateTaxes	36872000	usd
	csr	Property Operating Expenses Excluding Real Estate Taxes PropertyOperatingExpensesExcludingRealEstateTaxes	39214000	usd
CY2024Q2	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	7081000	usd
CY2023Q2	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	7174000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15300140	shares
CY2024Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2428290000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2420146000	usd
CY2024Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	578691000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	530703000	usd
CY2024Q2	us-gaap	Investments Investments	1849599000	usd
CY2023Q4	us-gaap	Investments Investments	1889443000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14328000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8630000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1084000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	639000	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	34414000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	27649000	usd
CY2024Q2	us-gaap	Assets Assets	1899425000	usd
CY2023Q4	us-gaap	Assets Assets	1926361000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	52885000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	62754000	usd
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	48000000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	30000000	usd
CY2024Q2	us-gaap	Unsecured Debt UnsecuredDebt	299490000	usd
CY2023Q4	us-gaap	Unsecured Debt UnsecuredDebt	299459000	usd
CY2024Q2	us-gaap	Secured Debt SecuredDebt	584193000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	586563000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	984568000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	978776000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	100
CY2024Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	100
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	166000	shares
CY2024Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	166000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	166000	shares
CY2023Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	16560000	usd
CY2024Q2	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	16560000	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	16560000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	16560000	usd
CY2024Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3881000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3881000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3881000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3881000	shares
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	97036000	usd
CY2024Q2	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	97036000	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	93530000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	93530000	usd
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15057000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15057000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14963000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14963000	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	1167055000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1165694000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-579139000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-548273000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-749000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1119000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	680697000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	709832000	usd
CY2024Q2	csr	Noncontrolling Interest In Operating Partnerships And Preferred Unit Holders NoncontrollingInterestInOperatingPartnershipsAndPreferredUnitHolders	216901000	usd
CY2023Q4	csr	Noncontrolling Interest In Operating Partnerships And Preferred Unit Holders NoncontrollingInterestInOperatingPartnershipsAndPreferredUnitHolders	220544000	usd
CY2024Q2	csr	Noncontrolling Interest In Consolidated Real Estate Entities NoncontrollingInterestInConsolidatedRealEstateEntities	699000	usd
CY2023Q4	csr	Noncontrolling Interest In Consolidated Real Estate Entities NoncontrollingInterestInConsolidatedRealEstateEntities	649000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	898297000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	931025000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1899425000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1926361000	usd
CY2024Q2	us-gaap	Revenues Revenues	65043000	usd
CY2023Q2	us-gaap	Revenues Revenues	64776000	usd
	us-gaap	Revenues Revenues	129549000	usd
	us-gaap	Revenues Revenues	132673000	usd
CY2024Q2	csr	Property Operating Expenses Excluding Real Estate Taxes PropertyOperatingExpensesExcludingRealEstateTaxes	18108000	usd
CY2023Q2	csr	Property Operating Expenses Excluding Real Estate Taxes PropertyOperatingExpensesExcludingRealEstateTaxes	17872000	usd
	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	13386000	usd
	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	14755000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2222000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2247000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4552000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4815000	usd
CY2024Q2	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-510000	usd
CY2023Q2	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-53000	usd
	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-1330000	usd
	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-305000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25714000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24371000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52726000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50364000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4216000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4162000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8839000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11885000	usd
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	57851000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	55879000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	117705000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	121338000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-67000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-577000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	60092000	usd
CY2024Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2023Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2864000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2864000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	7192000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5966000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	11267000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	68563000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	9332000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	8641000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	18539000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	18960000	usd
CY2024Q2	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	477000	usd
CY2023Q2	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	295000	usd
	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	817000	usd
	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	344000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1663000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2380000	usd
	us-gaap	Profit Loss ProfitLoss	-6455000	usd
	us-gaap	Profit Loss ProfitLoss	49947000	usd
CY2024Q2	csr	Preferred Stock Dividends PreferredStockDividends	160000	usd
CY2023Q2	csr	Preferred Stock Dividends PreferredStockDividends	160000	usd
	csr	Preferred Stock Dividends PreferredStockDividends	320000	usd
	csr	Preferred Stock Dividends PreferredStockDividends	320000	usd
CY2024Q2	csr	Noncontrolling Interest In Net Income Loss Operating Partnerships And Preferred Unit Holders Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsAndPreferredUnitHoldersNonredeemable	-561000	usd
CY2023Q2	csr	Noncontrolling Interest In Net Income Loss Operating Partnerships And Preferred Unit Holders Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsAndPreferredUnitHoldersNonredeemable	-712000	usd
	csr	Noncontrolling Interest In Net Income Loss Operating Partnerships And Preferred Unit Holders Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsAndPreferredUnitHoldersNonredeemable	-1640000	usd
	csr	Noncontrolling Interest In Net Income Loss Operating Partnerships And Preferred Unit Holders Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsAndPreferredUnitHoldersNonredeemable	7854000	usd
CY2024Q2	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	34000	usd
CY2023Q2	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	35000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	66000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	65000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1296000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1863000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5201000	usd
	us-gaap	Net Income Loss NetIncomeLoss	41708000	usd
CY2024Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1607000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1607000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3214000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8415000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.55
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14987000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14987000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14947000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18313000	shares
	us-gaap	Profit Loss ProfitLoss	-6455000	usd
	us-gaap	Profit Loss ProfitLoss	49947000	usd
	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax	-370000	usd
	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax	-297000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-6085000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	50244000	usd
	csr	Comprehensive Income Attributable To Noncontrolling Interest Operating Partnership And Preferred Unit Holders ComprehensiveIncomeAttributableToNoncontrollingInterestOperatingPartnershipAndPreferredUnitHolders	-1700000	usd
	csr	Comprehensive Income Attributable To Noncontrolling Interest Operating Partnership And Preferred Unit Holders ComprehensiveIncomeAttributableToNoncontrollingInterestOperatingPartnershipAndPreferredUnitHolders	7804000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	66000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	65000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4451000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	42375000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	950296000	usd
	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	49627000	usd
	csr	Amortization Of Swap Settlements AmortizationOfSwapSettlements	297000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.46
	us-gaap	Dividends Common Stock DividendsCommonStock	23276000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2109000	usd
	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	0	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6718000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	179000	usd
	csr	Amortization Of Swap Settlements AmortizationOfSwapSettlements	370000	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	110000	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7320000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7320000	usd
CY2023Q2	csr	Amortization Of Swap Settlements AmortizationOfSwapSettlements	159000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	590000	usd
CY2023Q2	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	0	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5696000	usd
CY2023Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	5000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	965408000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	907085000	usd
CY2024Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-1823000	usd
CY2024Q2	csr	Amortization Of Swap Settlements AmortizationOfSwapSettlements	173000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.75
CY2024Q2	us-gaap	Dividends Common Stock DividendsCommonStock	11907000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	733000	usd
CY2024Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	110000	shares
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7320000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7320000	usd
CY2024Q2	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	0	usd
CY2024Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	19000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	898297000	usd
	us-gaap	Profit Loss ProfitLoss	49947000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	51295000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	60159000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2864000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2109000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1916000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-391000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1748000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2866000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5317000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3752000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	47264000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	45561000	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	13147000	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0	usd
	csr	Net Proceeds From Sale Of Real Estate And Other Investments NetProceedsFromSaleOfRealEstateAndOtherInvestments	18251000	usd
	csr	Net Proceeds From Sale Of Real Estate And Other Investments NetProceedsFromSaleOfRealEstateAndOtherInvestments	141587000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	1949000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	717000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	35586000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	25072000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-117000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-14000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28416000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	117246000	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	0	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	90000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3125000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	22796000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	58556000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	62279000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	40556000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	156790000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	100000000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7388000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6718000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	22090000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3214000	usd
	csr	Payments Of Ordinary Dividends Preferred Unitholders PaymentsOfOrdinaryDividendsPreferredUnitholders	320000	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	4596000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-45000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12705000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6143000	usd
	csr	Capital Expenditures Incurred But Not Yet Paid Net CapitalExpendituresIncurredButNotYetPaidNet	4915000	usd
	csr	Capital Expenditures Incurred But Not Yet Paid Net CapitalExpendituresIncurredButNotYetPaidNet	4638000	usd
	csr	Conversion Of Stock Amount Converted Net ConversionOfStockAmountConvertedNet	-1367000	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11907000	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	1220000	usd
	csr	Noncash Or Part Noncash Transaction Retirement Of Shares Withheld For Taxes NoncashOrPartNoncashTransactionRetirementOfSharesWithheldForTaxes	121000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	900000	usd
	csr	Noncash Interest Income NoncashInterestIncome	336000	usd
	csr	Noncash Interest Income NoncashInterestIncome	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	16762000	usd
	us-gaap	Interest Paid Net InterestPaidNet	11867000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14328000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8630000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9745000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1084000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	639000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	566000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15412000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9269000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10311000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USE OF ESTIMATES</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECLASSIFICATIONS</span></div>Certain previously reported amounts have been reclassified to conform to the current financial statement presentation. These reclassifications had no impact on net income (loss) as reported in the Condensed Consolidated Statements of Operations, total assets, liabilities or equity as reported in the Condensed Consolidated Balance Sheets and the classifications within the Condensed Consolidated Statements of Cash Flows. Centerspace reclassified certain items within the disaggregated revenue table included in Note 2.
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	952000	usd
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	1989000	usd
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	1857000	usd
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	1575000	usd
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	1192000	usd
CY2024Q2	csr	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	6433000	usd
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	13998000	usd
CY2024Q2	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	60394000	usd
CY2023Q2	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	60528000	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	120428000	usd
CY2024Q2	us-gaap	Variable Lease Income VariableLeaseIncome	3558000	usd
CY2023Q2	us-gaap	Variable Lease Income VariableLeaseIncome	3017000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1091000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1231000	usd
CY2024Q2	us-gaap	Revenues Revenues	65043000	usd
CY2023Q2	us-gaap	Revenues Revenues	64776000	usd
	us-gaap	Revenues Revenues	129549000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-67000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	60100000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1700000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	893000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKET CONCENTRATION RISK</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to increased exposure from economic and other competitive factors specific to markets where it holds a significant percentage of the carrying value of its real estate portfolio. As of June 30, 2024, Centerspace held more than 10% of the carrying value of its real estate portfolio in the Minneapolis, Minnesota and Denver, Colorado markets.</span></div>
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2024Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2024Q2	us-gaap	Advertising Expense AdvertisingExpense	742000	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	744000	usd
CY2024Q2	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	-137000	usd
	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	-755000	usd
	csr	Number Of Apartment Community Assets Subject To Insurance Recoveries NumberOfApartmentCommunityAssetsSubjectToInsuranceRecoveries	6	apartmentcommunity
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1300000	usd
CY2024Q2	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	1600000	usd
	csr	Ratio Of Units Exchanged For Shares RatioOfUnitsExchangedForShares	1
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1296000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1863000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5201000	usd
CY2024Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1607000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1607000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3214000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3214000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2903000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3470000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8415000	usd
CY2024Q2	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable	0	usd
CY2023Q2	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable	0	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable	0	usd
CY2024Q2	csr	Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount	0	usd
CY2023Q2	csr	Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount	0	usd
	csr	Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount	0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2903000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3470000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8415000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14972000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14949000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14947000	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q2	csr	Incremental Common Shares Attributable To Conversion Of Restricted Stock IncrementalCommonSharesAttributableToConversionOfRestrictedStock	0	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14972000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2024Q2	csr	Noncontrolling Interests In Operating Partnership Units Outstanding NoncontrollingInterestsInOperatingPartnershipUnitsOutstanding	828000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15100000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15000000.0	shares
CY2022Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000.0	usd
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	4700000	usd
CY2024Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2024Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	0	usd
CY2024Q2	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	0
CY2023Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	105000	shares
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5696000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	935999000	usd
CY2024Q2	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0362
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	921124000	usd
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0354
	csr	Debt Instrument Weighted Average Maturity DebtInstrumentWeightedAverageMaturity	P5Y8M19D
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	608000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1134000	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3708000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3968000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	931683000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	916022000	usd
CY2024Q2	csr	Number Of Real Estate Properties Unencumbered NumberOfRealEstatePropertiesUnencumbered	45	apartmentcommunity
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3735000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	84290000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	102809000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	48666000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	118321000	usd
CY2024Q2	csr	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	578178000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	935999000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	608000	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3708000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	931683000	usd
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	690000	usd
CY2023Q2	csr	Number Of Acquisitions During Period NumberOfAcquisitionsDuringPeriod	0	acquisition
	csr	Number Of Acquisitions During Period NumberOfAcquisitionsDuringPeriod	0	acquisition
CY2024Q2	csr	Number Of Acquisitions During Period NumberOfAcquisitionsDuringPeriod	0	acquisition
	csr	Number Of Acquisitions During Period NumberOfAcquisitionsDuringPeriod	0	acquisition
	csr	Number Of Disposal Transactions During Period NumberOfDisposalTransactionsDuringPeriod	2	transaction
	csr	Number Of Disposal Transactions During Period NumberOfDisposalTransactionsDuringPeriod	4	transaction
CY2024Q2	us-gaap	Revenues Revenues	65043000	usd
CY2024Q2	csr	Property Operating Expense PropertyOperatingExpense	25189000	usd
CY2024Q2	csr	Net Operating Income Loss NetOperatingIncomeLoss	39854000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2222000	usd
CY2024Q2	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-510000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25714000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4216000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	9332000	usd
CY2024Q2	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	477000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1663000	usd
CY2023Q2	us-gaap	Revenues Revenues	64776000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4162000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	8641000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	18539000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	18960000	usd
CY2024Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2428290000	usd
CY2024Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	578691000	usd
CY2024Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1849599000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14328000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1084000	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	34414000	usd
CY2024Q2	us-gaap	Assets Assets	1899425000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2420146000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	530703000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1889443000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8630000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	639000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	27649000	usd
CY2023Q4	us-gaap	Assets Assets	1926361000	usd
CY2023Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2900000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2900000	usd
	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	1000000.0	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1000000.0	usd
CY2024Q2	csr	Number Of Real Estate Technology Venture Funds With Unfunded Commitments NumberOfRealEstateTechnologyVentureFundsWithUnfundedCommitments	2	realestatetechnologyventurefund
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	775000	shares
CY2015Q3	csr	Share Based Compensation Arrangement By Share Based Payment Award Term Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward	P10Y
CY2024Q1	us-gaap	Share Price SharePrice	58.20
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	733000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	590000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1500000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000798359-24-000100-index-headers.html	Edgar Link	pending
0000798359-24-000100-index.html	Edgar Link	pending
0000798359-24-000100.txt	Edgar Link	pending
0000798359-24-000100-xbrl.zip	Edgar Link	pending
centerspace-secondamendmen.htm	Edgar Link	pending
centerspace063024-10qex311.htm	Edgar Link	pending
centerspace063024-10qex312.htm	Edgar Link	pending
centerspace063024-10qex321.htm	Edgar Link	pending
centerspace063024-10qex322.htm	Edgar Link	pending
csr-20240630.htm	Edgar Link	pending
csr-20240630.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
csr-20240630_cal.xml	Edgar Link	unprocessable
csr-20240630_def.xml	Edgar Link	unprocessable
csr-20240630_lab.xml	Edgar Link	unprocessable
csr-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
csr-20240630_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CSR
Centerspace Stock $csr

2024 Q3 Form 10-Q Financial Statement

#000079835924000100 Filed on July 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSR Centerspace Stock $csr

2024 Q3 Form 10-Q Financial Statement

#000079835924000100 Filed on July 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSR
Centerspace Stock $csr